Misplaced Pages

Bufetolol

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Bufetolol
Names
IUPAC name 1-(tert-Butylamino)-3-propan-2-ol
Identifiers
CAS Number
3D model (JSmol)
ChEMBL
ChemSpider
KEGG
PubChem CID
UNII
CompTox Dashboard (EPA)
InChI
  • InChI=1S/C18H29NO4/c1-18(2,3)19-11-14(20)12-22-16-8-4-5-9-17(16)23-13-15-7-6-10-21-15/h4-5,8-9,14-15,19-20H,6-7,10-13H2,1-3H3Key: AKLNLVOZXMQGSI-UHFFFAOYSA-N
  • InChI=1/C18H29NO4/c1-18(2,3)19-11-14(20)12-22-16-8-4-5-9-17(16)23-13-15-7-6-10-21-15/h4-5,8-9,14-15,19-20H,6-7,10-13H2,1-3H3Key: AKLNLVOZXMQGSI-UHFFFAOYAN
SMILES
  • CC(C)(C)NCC(COC1=CC=CC=C1OCC2CCCO2)O
Properties
Chemical formula C18H29NO4
Molar mass 323.433 g·mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references
Chemical compound

Bufetolol is a beta-adrenoceptor antagonist.

References

  1. Sada, H; Harada, S; Ban, T (1983). "Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles". Naunyn-Schmiedeberg's Archives of Pharmacology. 324 (1): 50–7. doi:10.1007/bf00647838. PMID 6138715.
Adrenergic receptor modulators
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories: